Interventional News Issue 62 – June 2016

355

Highlights: -Immunotherapy could transform systemic power of locoregional IO treatments -Randomised data favour Y-90 therapy over conventional chemoembolization in patients with unresectable hepatocellular carcinoma -Kamran Ahrar: Chemoembolization -Luigi Solbiati: Fusion imaging -Profile: Constantinos Sofocleous